127 related articles for article (PubMed ID: 8965196)
1. Cocaine congeners as PET imaging probes for dopamine terminals.
Brownell AL; Elmaleh DR; Meltzer PC; Shoup TM; Brownell GL; Fischman AJ; Madras BK
J Nucl Med; 1996 Jul; 37(7):1186-92. PubMed ID: 8965196
[TBL] [Abstract][Full Text] [Related]
2. Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT.
Wüllner U; Pakzaban P; Brownell AL; Hantraye P; Burns L; Shoup T; Elmaleh D; Petto AJ; Spealman RD; Brownell GL
Exp Neurol; 1994 Apr; 126(2):305-9. PubMed ID: 7925829
[TBL] [Abstract][Full Text] [Related]
3. SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.
Fischman AJ; Babich JW; Elmaleh DR; Barrow SA; Meltzer P; Hanson RN; Madras BK
J Nucl Med; 1997 Jan; 38(1):144-50. PubMed ID: 8998169
[TBL] [Abstract][Full Text] [Related]
4. Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism.
Hantraye P; Brownell AL; Elmaleh D; Spealman RD; Wüllner U; Brownell GL; Madras BK; Isacson O
Neuroreport; 1992 Mar; 3(3):265-8. PubMed ID: 1515582
[TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.
Wong DF; Yung B; Dannals RF; Shaya EK; Ravert HT; Chen CA; Chan B; Folio T; Scheffel U; Ricaurte GA
Synapse; 1993 Oct; 15(2):130-42. PubMed ID: 8259524
[TBL] [Abstract][Full Text] [Related]
6. Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT.
Morris ED; Babich JW; Alpert NM; Bonab AA; Livni E; Weise S; Hsu H; Christian BT; Madras BK; Fischman AJ
Synapse; 1996 Nov; 24(3):262-72. PubMed ID: 8923667
[TBL] [Abstract][Full Text] [Related]
7. PET studies on brain monoamine transporters with carbon-11-beta-CIT in Parkinson's disease.
Laihinen AO; Rinne JO; Någren KA; Lehikoinen PK; Oikonen VJ; Ruotsalainen UH; Ruottinen HM; Rinne UK
J Nucl Med; 1995 Jul; 36(7):1263-7. PubMed ID: 7790953
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys.
Kanazawa M; Ohba H; Harada N; Kakiuchi T; Muramatsu S; Tsukada H
J Nucl Med; 2016 Feb; 57(2):303-8. PubMed ID: 26564319
[TBL] [Abstract][Full Text] [Related]
9. Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane.
Madras BK; Spealman RD; Fahey MA; Neumeyer JL; Saha JK; Milius RA
Mol Pharmacol; 1989 Oct; 36(4):518-24. PubMed ID: 2811854
[TBL] [Abstract][Full Text] [Related]
10. Preparation and biological evaluation of iodine-125-IACFT: a selective SPECT agent for imaging dopamine transporter sites.
Elmaleh DR; Fischman AJ; Shoup TM; Byon C; Hanson RN; Liang AY; Meltzer PC; Madras BK
J Nucl Med; 1996 Jul; 37(7):1197-202. PubMed ID: 8965198
[TBL] [Abstract][Full Text] [Related]
11. [18F]CFT ([18F]WIN 35,428), a radioligand to study the dopamine transporter with PET: biodistribution in rats.
Haaparanta M; Bergman J; Laakso A; Hietala J; Solin O
Synapse; 1996 Aug; 23(4):321-7. PubMed ID: 8855517
[TBL] [Abstract][Full Text] [Related]
12. Striatal uptake of the dopamine reuptake ligand [11C]beta-CFT is reduced in Alzheimer's disease assessed by positron emission tomography.
Rinne JO; Sahlberg N; Ruottinen H; Någren K; Lehikoinen P
Neurology; 1998 Jan; 50(1):152-6. PubMed ID: 9443472
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain.
Bergström KA; Halldin C; Hall H; Lundkvist C; Ginovart N; Swahn CG; Farde L
Eur J Nucl Med; 1997 Jun; 24(6):596-601. PubMed ID: 9169564
[TBL] [Abstract][Full Text] [Related]
14. Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model.
Brownell AL; Canales K; Chen YI; Jenkins BG; Owen C; Livni E; Yu M; Cicchetti F; Sanchez-Pernaute R; Isacson O
Neuroimage; 2003 Oct; 20(2):1064-75. PubMed ID: 14568476
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.
Nurmi E; Bergman J; Eskola O; Solin O; Hinkka SM; Sonninen P; Rinne JO
J Cereb Blood Flow Metab; 2000 Nov; 20(11):1604-9. PubMed ID: 11083235
[TBL] [Abstract][Full Text] [Related]
16. PET examination of the monoamine transporter with [11C]beta-CIT and [11C]beta-CFT in early Parkinson's disease.
Rinne JO; Laihinen A; Någren K; Ruottinen H; Ruotsalainen U; Rinne UK
Synapse; 1995 Oct; 21(2):97-103. PubMed ID: 8584980
[TBL] [Abstract][Full Text] [Related]
17. [O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations.
Lundkvist C; Halldin C; Swahn CG; Hall H; Karlsson P; Nakashima Y; Wang S; Milius RA; Neumeyer JL; Farde L
Nucl Med Biol; 1995 Oct; 22(7):905-13. PubMed ID: 8547888
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.
Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM
J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892
[TBL] [Abstract][Full Text] [Related]
19. Distribution of cocaine recognition sites in monkey brain: II. Ex vivo autoradiography with [3H]CFT and [125I]RTI-55.
Kaufman MJ; Madras BK
Synapse; 1992 Oct; 12(2):99-111. PubMed ID: 1481136
[TBL] [Abstract][Full Text] [Related]
20. The influence of residual nor-β-CFT in 11C CFT injection on the Parkinson disease diagnosis: a 11C CFT PET study.
Huang T; Wang H; Tang G; Liang X; Shi X; Zhang X
Clin Nucl Med; 2012 Aug; 37(8):743-7. PubMed ID: 22785500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
